Changsong Qi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Ejection Fraction

Circulating Tumor

Top Venues

Nature medicine

Cancer research

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Changsong Qi, Chang Liu, Jifang Gong, Dan Liu, Xicheng Wang, Panpan Zhang, Yanru Qin, Sai Ge, Miao Zhang, Zhi Peng, Jun Zhou, Zhihao Lu, Ming Lu, Yanshuo Cao, Jiajia Yuan, Yakun Wang, Zhenghang Wang, Ran Xue, Xiaohui Peng, Yumeng Wang, Daijing Yuan, Jian Li, Xiaotian Zhang, Lin Shen
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results. Nature medicine 30 (8) (2024)
Changsong Qi, Chang Liu, Jifang Gong, Dan Liu, Xicheng Wang, Panpan Zhang, Yanru Qin, Sai Ge, Miao Zhang, Zhi Peng, Jun Zhou, Zhihao Lu, Ming Lu, Yanshuo Cao, Jiajia Yuan, Yakun Wang, Zhenghang Wang, Ran Xue, Xiaohui Peng, Yumeng Wang, Daijing Yuan, Jian Li, Xiaotian Zhang, Lin Shen
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results. Nature medicine (2024)
Changsong Qi, Chang Liu, Jifang Gong, Dan Liu, Xicheng Wang, Panpan Zhang, Yanru Qin, Sai Ge, Miao Zhang, Zhi Peng, Jun Zhou, Zhihao Lu, Ming Lu, Yanshuo Cao, Jiajia Yuan, Yakun Wang, Zhenghang Wang, Ran Xue, Xiaohui Peng, Yumeng Wang, Daijing Yuan, Jian Li, Xiaotian Zhang, Lin Shen
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results. Nature medicine 30 (8) (2024)
Licui Jiang, Fengtao You, Hai Wu, Changsong Qi, Shufen Xiang, Ping Zhang, Huimin Meng, Min Wang, Jiequn Huang, Yafen Li, Dan Chen, Gangli An, Nan Yang, Bozhen Zhang, Lin Shen, Lin Yang
B7-H3-Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity Against Solid Tumors. Cancer research (2024)
Changsong Qi, Ting Zhou, Yuezong Bai, Hui Chen, Jiajia Yuan, Feilong Zhao, Chang Liu, Mingyang Ma, Ting Bei, Shiqing Chen, Xiaochen Zhao, Chunzhu Chen, Lin Shen
China Special Issue on Gastrointestinal Tumor-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment. International journal of cancer (2023)